Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment-Reference-Cited by-同舟云学术

Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment

Published:2022-04-19 Issue:6 Volume:37 Page:1136-1146
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Geusens Piet¹²^ORCID,Bevers Melissa SAM³⁴⁵^ORCID,van Rietbergen Bert⁵⁶^ORCID,Messina Osvaldo D⁷^ORCID,Lespessailles Eric⁸^ORCID,Oliveri Beatriz⁹^ORCID,Chapurlat Roland¹⁰^ORCID,Engelke Klaus¹¹¹²^ORCID,Chines Arkadi¹³^ORCID,Huang Shuang¹³^ORCID,Saag Kenneth G¹⁴^ORCID,van den Bergh Joop P¹²³⁴^ORCID

Affiliation:

1. Department of Internal Medicine Subdivision of Rheumatology, Maastricht University Medical Center Maastricht The Netherlands

2. Department of Medicine and Life Sciences Hasselt University Hasselt Belgium

3. Department of Internal Medicine VieCuri Medical Center Venlo The Netherlands

4. NUTRIM School for Nutrition and Translational Research in Metabolism Maastricht University Medical Center Maastricht The Netherlands

5. Department of Biomedical Engineering Eindhoven University of Technology Eindhoven The Netherlands

6. Department of Orthopedic Surgery Maastricht University Medical Center Maastricht The Netherlands

7. IRO Medical Center Investigaciones Reumatologicas y Osteologicas SRL Buenos Aires Argentina

8. Regional Hospital of Orleans Translational Medicine Research Platform, PRIMMO Orleans France

9. INIGEM, Hospital de Clínicas José de San Martin Buenos Aires Argentina

10. INSERM UMR 1033 Université de Lyon, Hospital Edouard Herriot Lyon France

11. Bioclinica Inc Hamburg Germany

12. Department of Medicine 3 FAU University Erlangen‐Nürnberg and Universitätsklinikum Erlangen Erlangen Germany

13. Amgen Inc Thousand Oaks CA USA

14. University of Alabama at Birmingham Birmingham AL USA

Funder

Amgen

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4551

Reference40 articles.

1. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials

2. Use of Oral Corticosteroids and Risk of Fractures

3. The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis

4. Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

5. Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?;Endocrine Reviews;2023-05-30

2. Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis;European Journal of Endocrinology;2023-03-02

3. Denosumab prevented periprosthetic bone resorption better than risedronate after total hip arthroplasty;Journal of Bone and Mineral Metabolism;2023-02-06

4. Denosumab: Clinical Applications, Outcomes, and Perspectives in Osteoporosis;Pharmacological Interventions for Osteoporosis;2023

5. Pharmacological, Nutritional, and Rehabilitative Interventions to Improve the Complex Management of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review;Journal of Personalized Medicine;2022-10-01